Commercial Translation: IP Considerations and Strategy
Date and time
Location
Online event
A healthtech speaker series by the Commercial Translation team of Te Tītoki Mataora, the Medtech Research Translator.
About this event
For health technology start-ups, intellectual property (IP) is an important asset however, it can come with many questions; What does IP include? When should I consider IP protection? What does the process look like? Where can I go for assistance? This is a common challenge for early stage innovations and one to be prepared for when beginning your commercialisation journey.
Join us for an in-depth discussion with key IP experts who will speak to some of these common questions and answer those burning questions you may have.
This will be followed up with an open-mike session on May 31st, 12pm - 1pm as an open discussion for all, focussing on some of the key points brought up during the panel session and is an opportunity to share your experiences with others.
Speakers:
Nicola Johnstone is Head of Intellectual Property at Auckland UniServices Limited. She is a patent attorney, solicitor, and engineer. Nicola leads a team of patent attorneys that provide intellectual property advice to the University of Auckland staff and students. Nicola has over 20 years’ experience in the IP field, particularly with international patent law. Nicola has a particular interest in medical technologies, but has much experience working with electrical and mechanical inventions and ICT technologies. In more recent years Nicola has worked with many start-ups on IP strategy and management of technologies and IP.
Jane McHenry is a director of Potter IP having joined the firm in 2016. She is a Patent Attorney with extensive IP knowledge having worked in the industry for over 20 years. Jane combines her PhD and her experience as a patent examiner with her in-depth in-house patent experience dealing with issues internationally, not just in New Zealand. Having been involved on all sides of the IP world she adds a unique perspective that is incredibly valuable in assisting New Zealand businesses with developing and achieving their IP strategic goals. She has been involved in a diverse range of technology areas including biotechnology, medical devices and biofuels.
